Navigation Links
Access MediQuip's Rapid Response To Medtronic Infusion Pump Recall Protects Patients

Lake Mary, FL (PRWEB) July 24, 2013

Access MediQuip, the nation's first and largest surgical and implant management company, announced today that its industry leading Recall Management Service? (RMS) is helping protect patients nationwide following Class I recalls of a Medtronic infusion pump. Access MediQuip notified its payer partners immediately of the formal recalls of Medtronic's SynchroMed II Implantable Infusion Pump and identified which members were affected.

In June, Medtronic issued four medical device notifications about flaws with the SynchroMed infusion pumps, which are used to deliver pain and other medications. The flaws in the implant are linked to 14 patient deaths over 17 years. The U.S. Food and Drug Administration classified three of the notifications as Class I recalls, indicating the implantable device may cause serious adverse health consequences, including death. The fourth notification was classified as a Class II recall, indicating the possibility of temporary or medically reversible adverse health consequences.

"When there's a surgical device recall such as Medtronic's, speed and precision is essential to protecting patients, especially with Class I and II recalls when a patient's life and safety is at stake," said Prakash Patel, MD, CEO of Access MediQuip. "RMS accelerates the delivery of recall notices to health plans, physicians, facilities, manufacturers, and patients."

When a recall is initiated, RMS leverages Access MediQuip's expansive database of facility, device, and case-related information to identify potentially affected patients through a series of reactive and proactive processes. This capability allows RMS to recognize patients who have already received a defective device and those currently scheduled to receive one. Access MediQuip provides its partners with this HIPAA-compliant corresponding case information, which includes member identification number, name of the facility where the procedure was or is to be performed, physician's name, serial number of the recalled implant, and date of service.

"Thanks to our RMS solution, we are able to provide our partners with the specific information they need concerning any implant recall and support their efforts to ensure patient safety," said Dr. Patel. "There is no better recall management solution on the market, which is why so many payers, facilities, and physicians have made RMS their service of choice."

About Access MediQuip

Access MediQuip is the largest and only company in the country that provides an integrated, comprehensive surgical and implant management solution (SIMS) program. With more than 16 years of experience, Access MediQuip provides payers with analytics to understand their implant spend, manage and control the high costs of implants and surgeries, and improve the quality and safety of surgical procedures, all while maintaining full access and choice of implants for facilities, surgeons and, ultimately, patients. The company was founded in 1997 and is headquartered in Lake Mary, Florida. For more information, please visit


Media Contact:
Lindsey Harris

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Image share project gives patients and physicians anytime, anywhere access to medical images
2. Equal access to care helps close survival gap for young African-American cancer patients
3. Premier issue of BioResearch Open Access launched by Mary Ann Liebert Inc. publishers
4. World Health Assembly endorses new plan to increase global access to vaccines
5. FDA Approves SonixGPS Needle Guidance Technology for Vascular Access Procedures
6. Researchers offer new approach to track former prisoners access to community HIV care
7. Revised geographic adjustments could improve accuracy of Medicare payments, will not solve access, quality problems
8. Access to clinical trials drives dramatic increases in survival from childhood cancer
9. Disabled Americans Battle for Access to Hotel Pools
10. Expanding Access to Medicaid Would Save Lives: Study
11. The ACCESS-EU study
Post Your Comments:
(Date:6/27/2016)... ... ... recently awarded their highest five-star rating to Best Buy Eyeglasses, an ... United States and Canada wear eyeglasses. Once considered to be a purely functional part ... fashion statement. Even celebrities use glasses as a way of creating an iconic image—like ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
Breaking Medicine Technology: